신생아 호흡곤란증 치료를 위한 새로운 합성 표면활성제

키워드

참고문헌 (77)

1. Avery ME, "Surface properties in relation to atelectasis and hyaline membrane disease", AMA J Dis Child, 97, pp.517~523 (1959)
2. Fujiwara T, "Artificial surfactant therapy in hyaline-membrane disease", Lancet, 1, pp.55~59 (1980)
3. Soll RF, "Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome", Cochrane Database Syst Rev, pp.000144~ (2001)
4. Curstedt T, "New synthetic surfactants--basic science", Biol Neonate, 87, pp.332~337 (2005)
5. Moya F, "Synthetic surfactants: where are we? Evidence from randomized, controlled clinical trials", J Perinatol, 29(2), pp.23~28 (2009)
6. Curstedt T, "Two hydrophobic low-molecular-mass protein fractions of pulmonary surfactant. Characterization and biophysical activity", Eur J Biochem, 168, pp.255~262 (1987)
7. Notter RH, "Component-specific surface and physiological activity in bovine-derived lung surfactants", Chem Phys Lipids, 114, pp.21~34 (2002)
8. Durand DJ, "Effects of a protein-free, synthetic surfactant on survival and pulmonary function in preterm lambs", J Pediatr, 107, pp.775~780 (1985)
9. Cochrane CG, "The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome", Am J Respir Crit Care Med, 153, pp.404~410 (1996)
10. Neergaard KV, "Neue auffassungen uber einen grundbegriff der atemmechanik. Die retraktionskraft der lunge, abhangig von der oberflachenspannung in den alveolen", Z Gesamt Exp Med, 66, pp.373~394 (1929)
11. Pattle RE, "Properties, function and origin of the alveolar lining layer", Nature, 175, pp.1125~1126 (1955)
12. Clements JA, "Surface tension of lung extracts", Proc Soc Exp Biol Med, 95, pp.170~172 (1957)
13. Chu J, "Neonatal pulmonary ischemia. I. Clinical and physiological studies", Pediatrics, 40, pp.709~782 (1967)
14. Enhorning G, "Lung expansion in the premature rabbit fetus after tracheal deposition of surfactant", Pediatrics, 50, pp.58~66 (1972)
15. Adams FH, "Effects of tracheal instillation of natural surfactant in premature lambs. I. Clinical and autopsy findings", Pediatr Res, 12, pp.841~848 (1978)
16. Robertson B, "A 2-year follow up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome. Collaborative European Multicentre Study Group", Eur J Pediatr, 151, pp.372~376 (1992)
17. Hawgood S, "Effects of a surfactantassociated protein and calcium ions on the structure and surface activity of lung surfactant lipids", Biochemistry, 24, pp.184~190 (1985)
18. Whitsett J, "Composition of pulmonary surfactant lipids and proteins, In Fetal and Neonatal Physiology. 4th ed", pp.1084~1093 (2011), Elsevier
19. McCormack FX, "Structure, processing and properties of surfactant protein A", Biochem Biophys Acta, 1408, pp.109~ (1998)
20. Wright JR, "Immunoregulatory functions of surfactant proteins", Nat Rev Immunol, 5, pp.58~68 (2005)
21. Korfhagen TR, "Altered surfactant function and structure in SP-A gene targeted mice", Proc Natl Acad Sci U S A, 93, pp.9594~9599 (1996)
22. Crouch E, "Surfactant proteins a and d and pulmonary host defense", Annu Rev Physiol, 63, pp.521~554 (2001)
23. Kishore U, "Surfactant proteins SP-A and SP-D: structure, function and receptors", Mol Immunol, 43, pp.1293~1315 (2006)
24. Wert SE, "Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice", Proc Natl Acad Sci U S A, 97, pp.5972~5977 (2000)
25. Weaver TE, "Function of surfactant proteins B and C", Annu Rev Physiol, 63, pp.555~578 (2001)
26. Hawgood S, "Structure and properties of surfactant protein B", Biochim Biophys Acta, 1408, pp.150~160 (1998)
27. Waring AJ, "The role of charged amphipathic helices in the structure and function of surfactant protein B", J Pept Res, 66, pp.364~374 (2005)
28. Suzuki Y, "Reconstitution of tubular myelin from synthetic lipids and proteins associated with pig pulmonary surfactant", Am Rev Respir Dis, 140, pp.75~81 (1989)
29. Melton KR, "SP-B deficiency causes respiratory failure in adult mice", Am J Physiol Lung Cell Mol Physiol, 285, pp.543~549 (2003)
30. Glasser SW, "Altered stability of pulmonary surfactant in SP-C-deficient mice", Proc Natl Acad Sci U S A, 98, pp.6366~6371 (2001)
31. Notter RH, "Lung surfactants. Basic science and clinical applications" (2000), Marcel Dekker
32. Possmayer F, "Pulmonary surfactant", Can J Biochem Cell Biol, 62, pp.1121~1133 (1984)
33. Lawrie GA, "Spreading properties of dimyristoyl phosphatidylcholine at the air", water interface, 1996, pp.79, 1~8
34. Hawco MW, "Lipid fluidity in lung surfactant: monolayers of saturated and unsaturated lecithins", J Appl Physiol, 51, pp.509~515 (1981)
35. Metcalfe IL, "Lung expansion and survival in rabbit neonates treated with surfactant extract", J Appl Physiol, 53, pp.838~843 (1982)
36. Robertson B, "Synthetic surfactants to treat neonatal lung disease", Mol Med Today, 6, pp.119~124 (2000)
37. Veldhuizen EJ, "Role of pulmonary surfactant components in surface film formation and dynamics", Biochim Biophys Acta, 1467, pp.255~270 (2000)
38. Logan JW, "Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials", Ther Clin Risk Manag, 5, pp.251~260 (2009)
39. Morley CJ, "Randomized trial of artificial surfactant (ALEC) given at birth to babies from 23 to 34 weeks gestation", Early Hum Dev, 17, pp.41~54 (1988)
40. Phibbs RH, "Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease", Pediatrics, 88, pp.1~9 (1991)
41. Kallberg Y, "Prediction of amyloid fibril-forming proteins", J Biol Chem, 276, pp.12945~12950 (2001)
42. Takei T, "The surface properties of chemically synthesized peptides analogous to human pulmonary surfactant protein SP-C", Biol Pharm Bull, 19, pp.1247~1253 (1996)
43. Davis AJ, "Lung function in premature lambs and rabbits treated with a recombinant SP-C surfactant", Am J Respir Crit Care Med, 157, pp.553~559 (1998)
44. Hawgood S, "Lung function in premature rabbits treated with recombinant human surfactant protein-C", Am J Respir Crit Care Med, 154, pp.484~490 (1996)
45. Johansson J, "Secondary structure and biophysical activity of synthetic analogues of the pulmonary surfactant polypeptide SP-C", Biochem J, 307, pp.535~541 (1995)
46. Nilsson G, "Synthetic peptide-containing surfactants- evaluation of transmembrane versus amphipathic helices and surfactant protein C poly-valyl to poly-leucyl substitution", Eur J Biochem, 255, pp.116~124 (1998)
47. Palmblad M, "Biophysical activity of an artificial surfactant containing an analogue of surfactant protein (SP)-C and native SP-B", Biochem J, 339, pp.381~386 (1999)
48. Johansson J, "A synthetic surfactant based on a poly-Leu SP-C analog and phospholipids: effects on tidal volumes and lung gas volumes in ventilated immature newborn rabbits", J Appl Physiol, 95, pp.2055~2063 (2003)
49. Curstedt T, "Different effects of surfactant proteins B and C - implications for development of synthetic surfactants", Neonatology, 97, pp.367~372 (2010)
50. Spragg RG, "Effect of recombinant SP-C surfactant in a porcine lavage model of acute lung injury", J Appl Physiol, 88, pp.674~681 (2000)
51. Taut FJ, "A Search for subgroups of patients with ARDS who may benefit from surfactant replacement therapy: a pooled analysis of five studies with recombinant surfactant protein-C surfactant (Venticute)", Chest, 134, pp.724~732 (2008)
52. Almlen A, "Synthetic surfactant based on analogues of SP-B and SP-C is superior to single-peptide surfactants in ventilated premature rabbits", Neonatology, 98, pp.91~99 (2010)
53. Spragg RG, "Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury", Am J Respir Crit Care Med, 183, pp.1055~1061 (2011)
54. Zhu Y, "KL4-surfactant(Lucinactant) protects human airway epithelium from hyperoxia", Pediatr Res, 64, pp.154~158 (2008)
55. Cochrane CG, "Pulmonary surfactant protein B (SP-B): structure-function relationships", Science, 254, pp.566~568 (1991)
56. Andersson S, "Oxidative inactivation of surfactants", Lung, 177, pp.179~189 (1999)
57. Revak SD, "Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys", Pediatr Res, 39, pp.715~724 (1996)
58. Moya FR, "A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants", Pediatrics, 115, pp.1018~1029 (2005)
59. Sinha SK, "A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome", Pediatrics, 115, pp.1030~1038 (2005)
60. Moya F, "One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials", Pediatrics, 119, pp.1361~1370 (2007)
61. Notter RH, "Novel phospholipaseresistant lipid", peptide synthetic lung surfactants, 2007, pp.7, 932~944
62. Walther FJ, "Dynamic surface activity of a fully synthetic phospholipase-resistant lipid", peptide lung surfactant, 2007, pp.2, e1039~
63. Sato A, "SP-B and SP-C containing new synthetic surfactant for treatment of extremely immature lamb lung", PLoS One, 7, pp.e39392~ (2012)
64. Seehase M, "New Surfactant with SP-B and C Analogs Gives Survival Benefit after Inactivation in Preterm Lambs", PLoS One, 7, pp.e47631~ (2012)
65. Phelps SB, "Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 2: inflatable nasal tampons are less painful than dry hydrophilic nasal tampons", Emerg Med J, 28, pp.243~244 (2011)
66. Taeusch HW, "Inactivation of pulmonary surfactant due to seruminhibited adsorption and reversal by hydrophilic polymers: experimental", Biophys J, 89, pp.1769~1779 (2005)
67. Casals C, "Increase of C-reactive protein and decrease of surfactant protein A in surfactant after lung transplantation", Am J Respir Crit Care Med, 157, pp.43~49 (1998)
68. Lu KW, "Taeusch HW. Hyaluronan decreases surfactant inactivation in vitro", Pediatr Res, 57, pp.237~241 (2005)
69. William Taeusch H, "Nonionic polymers reverse inactivation of surfactant by meconium and other substances", Am J Respir Crit Care Med, 159, pp.1391~1395 (1999)
70. Kobayashi T, "Dextran restores albumin-inhibited surface activity of pulmonary surfactant extract", J Appl Physiol, 86, pp.1778~1784 (1999)
71. Calkovska A, "Biophysical and physiological properties of porcine surfactant enriched with polymyxin B", Biol Neonate, 88, pp.101~108 (2005)
72. Lu KW, "Combined effects of polymers and KL(4) peptide on surface activity of pulmonary surfactant lipids", Biochim Biophys Acta, 1798, pp.1129~1134 (2010)
73. McLean LR, "An amphipathic alpha-helical decapeptide in phosphatidylcholine is an effective synthetic lung surfactant", Am Rev Respir Dis, 147, pp.462~465 (1993)
74. Seurynck SL, "Simple, helical peptoid analogs of lung surfactant protein B", Chem Biol, 12, pp.77~88 (2005)
75. Walther FJ, "Surfactant protein B and C analogues", Mol Genet Metab, 71, pp.342~351 (2000)
76. Veldhuizen EJ, "Dimeric N-terminal segment of human surfactant protein B (dSP-B(1-25)) has enhanced surface properties compared to monomeric SP-B(1-25)", Biophys J, 79, pp.377~384 (2000)
77. Takei T, "Characterization of poly-leucine substituted analogues of the human surfactant protein SP-C", Biol Pharm Bull, 19, pp.1550~1555 (1996)

관련 논문AI추천